Diary - News
All news Biom’up obtains CE Mark for its HEMOBLASTTM Bellows Laparoscopic Applicator
Saint-Priest, France, July 12, 2018 – Biom’up (the "Company"), specialist of surgical hemostasis, today announces having obtained CE Mark for its Laparoscopic Applicator and thus extends its indications by enabling European surgeons to use HEMOBLAST Bellows hemostatic powder for both open and laparoscopic surgery, while continuing to benefit from the same advantages in terms of efficacy, simplicity and rapidity. This CE Mark attests to the conformity of the device with the essential health and safety requirements laid down by the applicable European regulations and attests that it has followed the appropriate conformity assessment procedures.
Read the full press release
